Security Snapshot

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock (PACB) Institutional Ownership

CUSIP: 69404D108

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

219

Shares (Excl. Options)

191,085,354

Price

$1.68

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,009,791
Value change
+$6,198,729
Number of holders
219
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
310,546,569
SEC-reported price per share
$1.48
Insider filing price
$1.48
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock is tracked under CUSIP 69404D108.
  • 219 institutions reported positions in Q2 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 229 to 219 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $248,545,218 to $320,814,751.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 219 institutions filings for Q2 2026.

Open SEC evidence

Security key

69404D108

Latest holder period

Q2 2026

13F holders

219

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
PACB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARK Investment Management LLC 9.6% -23% $46,459,009 -$11,673,187 29,781,416 -20% ARK Investment Management LLC 30 Jun 2026
BlackRock, Inc. 7.7% $25,381,202 22,865,948 BlackRock, Inc. 31 Mar 2025
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) 4.5% $16,574,088 13,366,200 EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) 30 Jun 2025
MADRONE CAPITAL PARTNERS, LLC 2.8% -57% $10,849,394 -$15,086,243 8,476,089 -58% Gregory Boyd Penner 30 Sep 2025
MILLENNIUM MANAGEMENT LLC 0.7% -88% $2,446,489 -$15,805,969 2,204,044 -87% Millennium Management LLC 31 Mar 2025

As of 30 Jun 2026, 219 institutional investors reported holding 191,085,354 shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock (PACB). This represents 62% of the company’s total 310,546,569 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
53%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 10% 32,339,550 +28% 0% $54,330,444
ARK Investment Management LLC 9.6% 29,781,416 -18% 0.33% $50,032,778
SOFTBANK GROUP CORP. 6.6% 20,451,570 0% 0.19% $34,358,638
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 13,397,934 +4.9% 0% $22,508,529
GEODE CAPITAL MANAGEMENT, LLC 2.4% 7,606,518 +9% 0% $12,782,429
Amova Asset Management Americas, Inc. 1.9% 6,009,715 -15% 0.13% $10,036,224
Sumitomo Mitsui Trust Group, Inc. 1.9% 6,009,715 -15% 0.01% $10,096,321
STATE STREET CORP 1.9% 5,961,175 -2.6% 0% $10,014,774
Point72 Asset Management, L.P. 1.5% 4,787,300 +1576% 0.01% $8,042,664
TWO SIGMA INVESTMENTS, LP 1.4% 4,242,599 +21% 0.01% $7,127,566
D. E. Shaw & Co., Inc. 1.4% 4,208,146 +16% 0% $7,069,686
MILLENNIUM MANAGEMENT LLC 1.3% 3,962,442 -19% 0% $6,656,903
GOLDMAN SACHS GROUP INC 1% 3,229,887 +227% 0% $5,426,210
CITADEL ADVISORS LLC 0.92% 2,845,903 +81% 0% $4,781,117
VANGUARD PORTFOLIO MANAGEMENT LLC 0.86% 2,671,916 -6.8% 0% $4,488,819
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.85% 2,652,298 +10% 0% $4,455,861
NORTHERN TRUST CORP 0.76% 2,352,786 +10% 0% $3,952,681
VANGUARD FIDUCIARY TRUST CO 0.7% 2,187,627 +10% 0% $3,675,213
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.69% 2,129,263 +24% 0% $3,577,162
Longaeva Partners L.P. 0.68% 2,118,231 0.1% $3,558,628
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 0.55% 1,694,546 -5.2% 0.18% $2,846,837
Birchview Capital, LP 0.43% 1,350,000 -10% 1.1% $2,268,000
BANK OF AMERICA CORP /DE/ 0.43% 1,348,131 -19% 0% $2,264,860
Invesco Ltd. 0.42% 1,297,091 -12% 0% $2,179,114
AQR CAPITAL MANAGEMENT LLC 0.42% 1,296,684 +71% 0% $2,178,430

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 191,085,354 $320,814,751 +$6,198,729 $1.68 219
2026 Q1 188,188,305 $248,545,218 -$19,852,834 $1.32 229
2025 Q4 200,682,911 $373,261,409 +$45,692,100 $1.87 213
2025 Q3 186,222,939 $237,845,533 -$15,544,161 $1.28 204
2025 Q2 198,429,992 $245,807,592 -$33,393,899 $1.24 201
2025 Q1 225,076,304 $265,438,365 -$42,568,126 $1.18 215
2024 Q4 259,359,536 $474,377,794 +$51,266,960 $1.83 224
2024 Q3 231,885,292 $394,223,882 -$15,146,412 $1.70 221
2024 Q2 242,322,324 $331,828,960 -$126,309,908 $1.37 221
2024 Q1 264,567,000 $991,987,863 -$194,324,005 $3.75 259
2023 Q4 280,691,608 $2,753,719,080 +$174,125,078 $9.81 264
2023 Q3 262,947,975 $2,195,398,479 +$60,147,076 $8.35 269
2023 Q2 253,730,383 $3,373,760,799 +$3,630,482 $13.30 261
2023 Q1 253,323,853 $2,930,177,608 +$337,446,210 $11.58 246
2022 Q4 224,875,103 $1,839,361,397 -$8,472,047 $8.18 224
2022 Q3 211,717,263 $1,230,031,332 -$113,902,446 $5.80 205
2022 Q2 225,422,707 $1,027,886,640 -$73,855,004 $4.42 210
2022 Q1 223,099,497 $2,031,587,303 +$56,829,128 $9.10 235
2021 Q4 205,231,110 $4,199,090,963 +$311,852,672 $20.46 242
2021 Q3 188,918,110 $4,827,498,627 +$390,443,256 $25.55 238
2021 Q2 172,487,642 $6,031,627,622 +$293,878,727 $34.97 253
2021 Q1 164,192,829 $5,468,916,669 -$280,136,379 $33.31 249
2020 Q4 140,067,694 $3,634,026,778 +$744,373,801 $25.94 149
2020 Q3 148,618,546 $1,467,458,670 +$444,724,505 $9.87 171
2020 Q2 108,792,315 $375,333,900 -$26,373,067 $3.45 145
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .